At a glance
ClinicalIndex Comparison RecordN/ACompleted· 88 enrolled
Drug / intervention
HP828-101 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds
In Brief
A clinical study evaluating HP828-101 and Hydrogel/Hydrocolloid for Diabetic Foot Ulcers and Pressure Ulcers. Completed, enrolled 88 participants across 11 sites.
Detailed Summary
To compare HP828-101 to standard of care for the management of partial or full thickness wounds
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Foot Ulcers, Pressure Ulcers
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2009
First PostedSep 2009
Primary CompletionJan 2011
TodayJul 2026
First PostedSep 3, 2009
Enrollment StartSep 1, 2009
Primary CompletionJan 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 16.8 years ago
Interventions
HP828-101device
Topical test article applied once daily
Hydrogel/Hydrocolloiddevice
Hydrogel for DFU and Hydrocolloid for PU (3M Tegaderm Hydrogel for DFU; ConvaTec DuoDERM Hydroactive Gel for PU); Topical test articles applied once daily